USD 0.04
(-1.76%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 135.05 Thousand USD | 63.89% |
2022 | 82.4 Thousand USD | 9.04% |
2021 | 75.57 Thousand USD | 132.99% |
2020 | 32.43 Thousand USD | -73.4% |
2019 | 121.92 Thousand USD | 107.83% |
2018 | 58.66 Thousand USD | 60.25% |
2017 | 36.61 Thousand USD | 11.11% |
2016 | 32.95 Thousand USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 11.57 Thousand USD | 11.16% |
2023 Q4 | 10.41 Thousand USD | -62.21% |
2023 Q3 | 27.56 Thousand USD | 149.34% |
2023 Q1 | 86.02 Thousand USD | 1595.37% |
2023 Q2 | 11.05 Thousand USD | -87.15% |
2023 FY | 135.05 Thousand USD | 63.89% |
2022 Q2 | 6645.00 USD | -90.6% |
2022 FY | 82.4 Thousand USD | 9.04% |
2022 Q4 | 5074.00 USD | 0.0% |
2022 Q3 | - USD | -100.0% |
2022 Q1 | 70.68 Thousand USD | 31.25% |
2021 Q3 | 2642.00 USD | -78.96% |
2021 Q1 | 6517.00 USD | 123.87% |
2021 Q2 | 12.56 Thousand USD | 92.73% |
2021 Q4 | 53.85 Thousand USD | 1938.49% |
2021 FY | 75.57 Thousand USD | 132.99% |
2020 FY | 32.43 Thousand USD | -73.4% |
2020 Q4 | 2911.00 USD | 0.0% |
2019 FY | 121.92 Thousand USD | 107.83% |
2018 FY | 58.66 Thousand USD | 60.25% |
2017 Q4 | 14.68 USD | 0.0% |
2017 FY | 36.61 Thousand USD | 11.11% |
2016 FY | 32.95 Thousand USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Medical Technologies Inc. | 3.19 Million USD | 95.768% |
Ansell Limited | 1.61 Billion USD | 99.992% |
Ansell Limited | 1.61 Billion USD | 99.992% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 184.64 Million USD | 99.927% |
BioLife Sciences Inc. | - USD | -Infinity% |
Psykey, Inc. | 419.29 Thousand USD | 67.79% |
ConvaTec Group Plc | 2.19 Billion USD | 99.994% |
ConvaTec Group Plc | 2.14 Billion USD | 99.994% |
Encision Inc. | 6.58 Million USD | 97.949% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 1.82 Million USD | 92.599% |
LifePoint, Inc. | -18.5 Thousand USD | 830.027% |
Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 98.018% |
Paradigm Medical Industries, Inc. | 772 Thousand USD | 82.506% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 986.22 Thousand USD | 86.306% |
Reflect Scientific, Inc. | 1.08 Million USD | 87.497% |
SmileDirectClub, Inc. | 470.74 Million USD | 99.971% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 99.993% |
SheerVision, Inc. | 3.49 Million USD | 96.141% |
United Health Products, Inc. | - USD | -Infinity% |
Vasamed, Inc. | 1.38 Million USD | 90.258% |
Wearable Health Solutions, Inc. | 745.09 Thousand USD | 81.874% |
Yubo International Biotech Limited | 104.28 Thousand USD | -29.508% |